SFBC Chairman and President Lisa Krinsky Selected as Ernst & Young's Regional Entrepreneur...

Business Editors & Health/Medical Writers

SFBC International, Inc. (Nasdaq: SFCC) a provider of specialized, outsourced drug development research services to the pharmaceutical and biotechnology industries, announced today that Lisa Krinsky, M.D., Chairman and President, has been named

As a regional winner, Krinsky will represent the state of Florida at Ernst & Young's International Conference November 23 in Palm Springs, where the National Entrepreneur of the Year winners will be announced.

The 2002 regional awards banquet was held Thursday night at the Renaissance Orlando Resort. The award honors entrepreneurs whose ingenuity, hard work, and perseverance have created and sustained successful, growing business ventures.

The selection of Krinsky - the only female award recipient of the evening -as the region's Health Care/Life Sciences Entrepreneur climaxed an evening that also recognized the achievement of entrepreneurs in the financial services, manufacturing, real estate/construction, consumer products, and technology categories.

"This award, while bearing my name, is really a reflection of the efforts of our executive team, clinical staff and all the employees at SFBC who have worked diligently to make us one of the largest Phase I and Phase II clinical trials provider in North America," said Krinsky. "I'm honored to have the opportunity to accept it on their behalf. It's humbling to have been selected considering the quality and deservedness of the other regional finalists. My goal - our goal - at SFBC is to continue to provide top-notch clinical development research services to our clients worldwide in order to maintain SFBC as the standard in clinical research."

The Entrepreneur Of The Year Awards program was created and is produced by Ernst & Young and sponsored nationally by USA Today, CNN, The Nasdaq(R) Stock Market, and the Kauffman Center for Entrepreneurial Leadership at the Ewing Marion Kauffman Foundation.

Lisa Krinsky, M.D. has served as the Chairman of the Board of Directors, President and secretary of SFBC since 1995.

About SFBC

SFBC International, Inc., is a rapidly expanding comprehensive provider of early clinical development studies and is one of the largest Phase I and Phase II clinical trials provider in North America. It currently provides more than 100 of the largest pharmaceutical and biotechnology companies globally with cost-effective, accurate information.

With a total of more than 750 beds and 12 discrete units, its facilities are located in the United States in: Miami and Fort Myers, Florida; Charlotte, North Carolina; Philadelphia, Pennsylvania; and, in Canada, in Montreal and Quebec City. These sites include state-of-the-art-bioanalytical laboratories and a clinical laboratory that opened in December of 2001. The Company's specialties in geriatrics, pediatrics, post-menopausal women, cardiac disease, diabetes, kidney disease, ophthalmology, HIV and dermatology include some of the most challenging special populations. In addition to its core Phase I and Phase II testing for both branded and generic pharmaceutical and biotechnology companies, SFBC provides Phase III and Phase IV trial management services and also offers laboratory services to other contract research organizations. Additional information is available at the company's website, http://www.sfbci.com.